Publication Cover
Chronobiology International
The Journal of Biological and Medical Rhythm Research
Volume 29, 2012 - Issue 1
497
Views
52
CrossRef citations to date
0
Altmetric
Short Communication

Comparison of β-Adrenergic and Glucocorticoid Signaling on Clock Gene and Osteoblast-Related Gene Expressions in Human Osteoblast

, , &
Pages 66-74 | Received 07 Jul 2011, Accepted 20 Oct 2011, Published online: 04 Jan 2012

REFERENCES

  • Balsalobre A, Damiola F, Schibler U. (1998). A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell. 93:929–937.
  • Blumsohn A, Herrington K, Hannon RA, Shao P, Eyre DR, Eastell R. (1994). The effect of calcium supplementation on the circadian rhythm of bone resorption. J. Clin. Endocrinol. Metab. 79:730–735.
  • Bonnet N, Benhamou CL, Brunet-Imbault B, Arlettaz A, Horcajada MN, Richard O, Vico L, Collomp K, Courteix D. (2005a). Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats. Bone. 37:622–633.
  • Bonnet N, Brunet-Imbault B, Arlettaz A, Horcajada MN, Collomp K, Benhamou CL, Courteix D. (2005b). Alteration of trabecular bone under chronic beta2 agonists treatment. Med. Sci. Sports Exerc. 37:1493–1501.
  • Bonnet N, Pierroz DD, Ferrari SL. (2008). Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis. J. Musculoskelet. Neuronal Interact. 8:94–104.
  • Burioka N, Takata M, Okano Y, Ohdo S, Fukuoka Y, Miyata M, Takane H, Endo M, Suyama H, Shimizu E. (2005). Dexamethasone influences human clock gene expression in bronchial epithelium and peripheral blood mononuclear cells in vitro. Chronobiol. Int. 22:585–590.
  • Chung S, Son GH, Kim K. (2011). Circadian rhythm of adrenal glucocorticoid: its regulation and clinical implications. Biochim. Biophys. Acta. 1812:581–591.
  • Duguay D, Cermakian N. (2009). The crosstalk between physiology and circadian clock proteins. Chronobiol. Int. 26:1479–1513.
  • Dykman TR, Gluck OS, Murphy WA, Hahn TJ, Hahn BH. (1985). Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum. 28:361–368.
  • Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G. (2005). Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature. 434:514–520.
  • Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. (1990). Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol. Rev. 70:963–985.
  • Fu L, Lee CC. (2003). The circadian clock: pacemaker and tumour suppressor. Nat. Rev. Cancer. 3:350–361.
  • Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G. (2005). The molecular clock mediates leptin-regulated bone formation. Cell. 122:803–815.
  • Fu L, Patel MS, Karsenty G. (2006). The circadian modulation of leptin-controlled bone formation. Prog. Brain Res. 153:177–188.
  • Fujioka A, Takashima N, Shigeyoshi Y. (2006). Circadian rhythm generation in a glioma cell line. Biochem. Biophys. Res. Commun. 346:169–174.
  • Greenspan SL, Dresner-Pollak R, Parker RA, London D, Ferguson L. (1997). Diurnal variation of bone mineral turnover in elderly men and women. Calcif. Tissue Int. 60:419–423.
  • Herzog ED. (2007). Neurons and networks in daily rhythms. Nat. Rev. Neurosci. 8:790–802.
  • Hirota T, Okano T, Kokame K, Shirotani-Ikejima H, Miyata T, Fukada Y. (2002). Glucose down-regulates Per1 and Per2 mRNA levels and induces circadian gene expression in cultured Rat-1 fibroblasts. J. Biol. Chem. 277:44244–44251.
  • Huang TS, Grodeland G, Sleire L, Wang MY, Kvalheim G, Laerum OD. (2009). Induction of circadian rhythm in cultured human mesenchymal stem cells by serum shock and cAMP analogs in vitro. Chronobiol. Int. 26:242–257.
  • Ihara H, Hirukawa K, Goto S, Togari A. (2005). ATP-stimulated interleukin-6 synthesis through P2Y receptors on human osteoblasts. Biochem. Biophys. Res. Commun. 326:329–334.
  • Inouye ST, Kawamura H. (1979). Persistence of circadian rhythmicity in a mammalian hypothalamic “island” containing the suprachiasmatic nucleus. Proc. Natl. Acad. Sci. U. S. A. 76:5962–5966.
  • Ishida A, Mutoh T, Ueyama T, Bando H, Masubuchi S, Nakahara D, Tsujimoto G, Okamura H. (2005). Light activates the adrenal gland: timing of gene expression and glucocorticoid release. Cell Metab. 2:297–307.
  • Kellenberger S, Muller K, Richener H, Bilbe G. (1998). Formoterol and isoproterenol induce c-fos gene expression in osteoblast-like cells by activating beta2-adrenergic receptors. Bone. 22:471–478.
  • Kodama D, Togari A. (2010). Modulation of potassium channels via the alpha(1B)-adrenergic receptor in human osteoblasts. Neurosci. Lett. 485:102–106.
  • Kondo A, Togari A. (2003). In vivo stimulation of sympathetic nervous system modulates osteoblastic activity in mouse calvaria. Am. J. Physiol. Endocrinol. Metab. 285:E661–E667.
  • Kondo A, Togari A. (2004). Activation of osteoblastic functions by a mediator of pain, bradykinin. Biochem. Pharmacol. 68:1423–1431.
  • Kondo H, Togari A. (2011). Continuous treatment with a low-dose beta-agonist reduces bone mass by increasing bone resorption without suppressing bone formation. Calcif. Tissue Int. 88:23–32.
  • Kondo H, Nifuji A, Takeda S, Ezura Y, Rittling SR, Denhardt DT, Nakashima K, Karsenty G, Noda M. (2005). Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system. J. Biol. Chem. 280:30192–30200.
  • Krieger DT, Allen W, Rizzo F, Krieger HP. (1971). Characterization of the normal temporal pattern of plasma corticosteroid levels. J. Clin. Endocrinol. Metab. 32:266–284.
  • Manolagas SC, Weinstein RS. (1999). New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J. Bone Miner. Res. 14:1061–1066.
  • Matsuda T, Kondo A, Tsunashima Y, Togari A. (2010). Inhibitory effect of vitamin K(2) on interleukin-1beta-stimulated proliferation of human osteoblasts. Biol. Pharm. Bull. 33:804–808.
  • Mendez-Ferrer S, Lucas D, Battista M, Frenette PS. (2008). Haematopoietic stem cell release is regulated by circadian oscillations. Nature. 452:442–447.
  • Moore RE, Smith CK2nd, Bailey CS, Voelkel EF, Tashjian AH Jr. (1993). Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ culture. Bone Miner. 23:301–315.
  • Obata K, Furuno T, Nakanishi M, Togari A. (2007). Direct neurite-osteoblastic cell communication, as demonstrated by use of an in vitro co-culture system. FEBS Lett. 581:5917–5922.
  • Ochiai E, Kitagawa H, Takada I, Fujiyama S, Sawatsubashi S, Kim MS, Mezaki Y, Tsushima Y, Takagi K, Azuma Y, Takeyama K, Yamaoka K, Kato S, Kamimura T. (2010). CDP/cut is an osteoblastic coactivator of the vitamin D receptor (VDR). J. Bone Miner. Res. 25:1157–1166.
  • Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int. 27:1911–1929.
  • Reddy AB, Maywood ES, Karp NA, King VM, Inoue Y, Gonzalez FJ, Lilley KS, Kyriacou CP, Hastings MH. (2007). Glucocorticoid signaling synchronizes the liver circadian transcriptome. Hepatology. 45:1478–1488.
  • Reppert SM, Weaver DR. (2002). Coordination of circadian timing in mammals. Nature. 418:935–941.
  • Schibler U, Sassone-Corsi P. (2002). A web of circadian pacemakers. Cell. 111:919–922.
  • Schlemmer A, Hassager C, Pedersen BJ, Christiansen C. (1994). Posture, age, menopause, and osteopenia do not influence the circadian variation in the urinary excretion of pyridinium crosslinks. J. Bone Miner. Res. 9:1883–1888.
  • Schlemmer A, Hassager C, Alexandersen P, Fledelius C, Pedersen BJ, Kristensen IO, Christiansen C. (1997). Circadian variation in bone resorption is not related to serum cortisol. Bone. 21:83–88.
  • Shao P, Ohtsuka-Isoya M, Shinoda H. (2003). Circadian rhythms in serum bone markers and their relation to the effect of etidronate in rats. Chronobiol. Int. 20:325–336.
  • Sherman BE, Chole RA. (2001). Effect of chemical sympathectomy with 6-hydroxydopamine on osteoclast activity in the gerbilline middle ear bulla. Otol. Neurotol. 22:237–241.
  • Silver R, LeSauter J, Tresco PA, Lehman MN. (1996). A diffusible coupling signal from the transplanted suprachiasmatic nucleus controlling circadian locomotor rhythms. Nature 382:810–813.
  • So AY, Bernal TU, Pillsbury ML, Yamamoto KR, Feldman BJ. (2009). Glucocorticoid regulation of the circadian clock modulates glucose homeostasis. Proc. Natl. Acad. Sci. U. S. A. 106:17582–17587.
  • Suzuki S, Toyabe S, Moroda T, Tada T, Tsukahara A, Iiai T, Minagawa M, Maruyama S, Hatakeyama K, Endoh K, Abo T. (1997). Circadian rhythm of leucocytes and lymphocytes subsets and its possible correlation with the function of the autonomic nervous system. Clin. Exp. Immunol. 110:500–508.
  • Takeda S. (2004). Leptin and beta-blockers in bone metabolism. Clin. Calcium 14:241–247.
  • Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G. (2002). Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305–317.
  • Togari A. (2002). Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells. Microsc. Res. Tech. 58:77–84.
  • Togari A, Arai M. (2008). Pharmacological topics of bone metabolism: the physiological function of the sympathetic nervous system in modulating bone resorption. J. Pharmacol. Sci. 106:542–546.
  • Togari A, Arai M, Mizutani S, Mizutani S, Koshihara Y, Nagatsu T. (1997). Expression of mRNAs for neuropeptide receptors and beta-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells. Neurosci. Lett. 233:125–128.
  • Togari A, Mogi M, Arai M, Yamamoto S, Koshihara Y. (2000). Expression of mRNA for axon guidance molecules, such as semaphorin-III, netrins and neurotrophins, in human osteoblasts and osteoclasts. Brain Res. 878:204–209.
  • Togari A, Arai M, Kondo A. (2005). The role of the sympathetic nervous system in controlling bone metabolism. Expert Opin. Ther. Targets 9:931–940.
  • Uemura T, Ohta Y, Nakao Y, Manaka T, Nakamura H, Takaoka K. (2010). Epinephrine accelerates osteoblastic differentiation by enhancing bone morphogenetic protein signaling through a cAMP/protein kinase A signaling pathway. Bone 47:756–765.
  • Wu X, Yu G, Parks H, Hebert T, Goh BC, Dietrich MA, Pelled G, Izadpanah R, Gazit D, Bunnell BA, Gimble JM. (2008). Circadian mechanisms in murine and human bone marrow mesenchymal stem cells following dexamethasone exposure. Bone 42:861–870.
  • Zvonic S, Ptitsyn AA, Kilroy G, Wu X, Conrad SA, Scott LK, Guilak F, Pelled G, Gazit D, Gimble JM. (2007). Circadian oscillation of gene expression in murine calvarial bone. J. Bone Miner. Res. 22:357–365.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.